GlobeNewsWire · REC · November 2, 2026
New Phase 2 REC-4881 Data Presented at CGA-IGC Show Deep, Durable Polyp Burden Reductions in FAP, with Activity Across the GI Tract and in Larger, Higher-Risk Polyps

Get the app for more
Explore stock news, insights and company research.
Get the app → Source: GlobeNewsWire ↗